Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication. Bravo et al

Published: 21 January 2021| Version 1 | DOI: 10.17632/ry9rk6tmcn.1
Contributor:
David Taylor

Description

Supplemental Information for Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication by Bravo et al

Files

Institutions

University of Texas at Austin

Categories

Cryo-Transmission Electron Microscopy

License